Back to search
Acute-on-Chronic Liver Failure (ACLF)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute-on-Chronic Liver Failure (ACLF) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute-on-Chronic Liver Failure (ACLF) trials you may qualify forThis study aims to evaluate the efficacy and safety of the double plasma cytokine adsorption system with sequential low-dose plasma exchange (DPCAS+LPE) in pati…
The artificial liver support system (ALSS) in patients with acute on chronic liver failure - the use of combined molecular adsorption system with double plasma…
Mesenchymal stromal cells (MSCs) are potential therapy for many diseases, with the ability of tissue regeneration, repair and immunomodulation. Acute-on-chronic…
Management of ACLF is mainly supportive. The poor outcomes lead physicians to consider liver transplantation as an option, even if controversial. In sicker reci…
Ten years after our team's publication, practices have changed considerably in the management of severe cirrhotic patients. This study will analyse these practi…
The study aims to test the effectiveness of new biomarkers (measurable molecules in our body) in predicting the health outcome of patients with liver cirrhosis…
This is a Phase 1, first-in-human (FIH) safety, proof-of-concept, two-part study of the genetically-engineered EGEN-5784 liver in combination with the metra® ex…
The goal of this clinical trial is to test the MEX-CD1 hemodialysis medical device in patients suffering from ACLF. The main questions it aims to answer are: *…